Table 5 Multiplicative factor by which the odds ratios for Kaposi's sarcoma and non-Hodgkin's lymphoma increased in relation to a doubling of the anti-EBV antibody titre

From: A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein–Barr virus in adults with human immunodeficiency virus-1

 

Factor (95% CI)

Adjusted factor (95% CI)

Kaposi's sarcoma

1.1 (0.9–1.2)

1.0 (0.8–1.2)

Non-Hodgkin's lymphoma

1.3 (0.9–1.7)

1.5 (0.9–2.3)

Back to article page